Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.
Canada and the rest of the democratic world are facing a “tsunami” of transnational and digital repression with the rise of ...
Ramaphosa urges ‘genuine’ public, private health sector collaboration over NHI; Business entities outline risks Middle East ...
As South Africa scales up utility-scale solar, what needs to be done well from the start? Find out from the very highly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results